Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small-cell lung cancer.

MLA

Oshita, Fumihiro, et al. “Phase I/II Study of Escalating Doses of Nedaplatin in Combination with Irinotecan for Advanced Non-Small-Cell Lung Cancer.” Cancer Chemotherapy and Pharmacology, vol. 52, no. 1, July 2003, pp. 73–78. EBSCOhost, https://doi.org/10.1007/s00280-003-0615-y.

APA

Oshita, F., Yamada, K., Kato, Y., Ikehara, M., Noda, K., Tanaka, G., Nomura, I., Suzuki, R., & Saito, H. (2003). Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology, 52(1), 73–78. https://doi.org/10.1007/s00280-003-0615-y

Chicago

Oshita, Fumihiro, Kouzo Yamada, Yuji Kato, Mizuki Ikehara, Kazumasa Noda, Gaku Tanaka, Ikuo Nomura, Rie Suzuki, and Haruhiro Saito. 2003. “Phase I/II Study of Escalating Doses of Nedaplatin in Combination with Irinotecan for Advanced Non-Small-Cell Lung Cancer.” Cancer Chemotherapy and Pharmacology 52 (1): 73–78. doi:10.1007/s00280-003-0615-y.